ArticleMolecular genetics and metabolism2016

A beta-blocker, propranolol, decreases the efficacy from enzyme replacement therapy in Pompe disease.

Sang-Oh Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.